Guru Ownership Trend
Guru Analysis for Regeneron Pharmaceuticals, Inc. (REGN)
Regeneron Pharmaceuticals, Inc. (REGN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 12 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.23 B.
Top institutional holders include Cliff Asness and Steven Cohen.
Notably, Mason Hawkins has expressed high conviction in this stock, allocating 5.70% of their equity portfolio to it.
Institutional sentiment is currently Bearish. This is evidenced by a $86.61 M net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 38.0%. Conversely, Catherine Wood reduced exposure by 99.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Regeneron Pharmaceuticals, Inc. (REGN)
Major holders include Cliff Asness ($768.52 M), Steven Cohen ($202.64 M), Mason Hawkins ($127.97 M). According to the latest reported data, 12 tracked investment managers collectively hold approximately 1.66 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $86.61 M, with 5 managers increasing positions and 7 managers reducing holdings.
During the most recent reporting period, 7 managers trimmed their positions, while 0 fully exited REGN. The total reported sell value was $362.1 M.
Yes, 0 managers opened new positions in REGN, and 5 increased their existing holdings. The total reported buy value was $275.49 M.
